colorectal cancer

News

Biosimilars unlock use of bevacizumab in bowel cancer by NHS

More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.

News

NICE backs five AI tools for bowel cancer screening

Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.

News

Takeda builds in cancer with monster $11.4bn Innovent deal

Takeda has partnered with China's Innovent for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2bn.

News

NICE relents on Takeda colorectal cancer drug Fruzaqla

Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.

Oncology

ASCO 2025: Building a stronger future in cancer care with a ...

From attending key oral sessions, clinical science symposiums and poster presentations to the simple pleasures of chatting with colleagues during coffee breaks, we left the

News

ASCO 25: Braftovi shows "unprecedented" survival gain

Pfizer's BRAF inhibitor Braftovi achieved a 51% reduction in the risk of death in the BREAKWATER trial, setting up full FDA approval.

Biosimilars unlock use of bevacizumab in bowel cancer by NHS

NICE backs five AI tools for bowel cancer screening

Takeda builds in cancer with monster $11.4bn Innovent deal

NICE relents on Takeda colorectal cancer drug Fruzaqla

ASCO 2025: Building a stronger future in cancer care with a ...

ASCO 25: Braftovi shows "unprecedented" survival gain

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

colorectal cancer

Editor's Picks